University of California San Francisco
Give to UCSF
Ten UCSF graduate students presented their research in accessible, 3-minute talks at the 2025 Grad Slam event. This year’s first-place talk was by Sophia Miliotis on how our immune system uses matchmaking skills to look for signs of viruses in cells that should be destroyed.
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found.
UCSF to archive Dr. Jay Levy’s HIV discovery notes: 70 cartons of handwritten records, photos, and correspondence.
The quest to defeat HIV/AIDS didn’t just turn a deadly virus into a manageable condition. It transformed science and health care.
The National AIDS Memorial has honored Dan Bernal, UCSF vice chancellor for community and government relations, for his lifelong contributions to health equity and community service through HIV activism and advocacy.
A new study on doxy-PEP sheds light on whether people who are regular users become resistance to this treatment, which often serves as a “morning after” pill to prevent sexually transmitted diseases.
A talk on how breathing affects our mood took first place at this year's Postdoc Slam event, which is held in celebration of National Postdoc Appreciation Week.
Results from a national study led by UCSF informed the first guidelines at the federal level in the U.S. to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.
AIDS Walk San Francisco and UC San Francisco continue to make a difference in the fight against HIV/AIDS with a strong partnership, raising funds for HIV programs and research.
The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities.
U.S. House Speaker Emerita Nancy Pelosi was honored at UCSF with the first ever Bay Area Global Health Alliance Leadership Award for championing policies supporting people living with AIDS/HIV throughout her career.
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.
Taking daily medication can be a challenge for many, leading to increased viral load over time. Injectable therapies remove that challenge.
Ever since San Francisco's AIDS Walk began, UCSF was there.
A short course of antibiotics, Doxy-PEP, can prevent some STIs after condomless sex.
A sexual health strategy called Doxy-PEP, which involves taking doxycycline after condomless sex, is highly effective in reducing bacterial STIs but is still associated with a limited rise in resistant strains of bacteria.
Three UCSF researchers were named 2022 fellows by the American Association for the Advancement of Science (AAAS), one of the highest honors in science.
Since 1983, Ward 86 has played a revolutionary role in HIV/AIDS treatment, and continues to develop ways to care for people living with HIV.
People who identify as lesbian, gay, bisexual, transgender or non-binary may have a higher risk for stroke at a younger age, and possibly a higher risk for recurrence than those who identify as straight and cisgender.
After two years of participating in mostly virtual events due to the pandemic, UCSF is rallying its community to come together in Golden Gate Park for AIDS Walk San Francisco on July 17 to raise funds for programs and services that benefit people of the Bay Area.
A significant proportion of bacterial sexually transmitted infections – gonorrhea, chlamydia, or syphilis – were prevented with a dose of doxycycline after unprotected sex, according to preliminary results of a clinical trial.
A groundbreaking national study led by UCSF finds that treating anal cancer precursor lesions reduces cancer risk for people with HIV.
Scientists at UCSF and Makerere University in Kampala, Uganda have developed an intervention that makes use of a portable laboratory testing technology to help HIV providers order, process, and receive HIV viral load results quickly, and shorten the time it takes for patients to get their results.
Individuals with HIV are more than twice as likely to die from sudden cardiac death (SCD) compared to the general population, and more likely to have hearts compromised by fibrosis, a factor that may play a role in increasing their susceptibility to SCD, according to new findings from a UCSF study.
This story is one in a series of first-person perspectives from those who are working on the frontlines to better understand, treat and prevent transmission of HIV and AIDS as well as COVID-19. You
This story is one in a series of first-person perspectives from those who are working on the frontlines to better understand, treat and prevent transmission of HIV and AIDS as well as COVID-19. You
